Cardiovascular disease (CVD) is the leading cause of death in the United States for both men and women. Although the precise number of people with elevated lipids depends on the definition chosen, it is clear that hyperlipidemia is one of the most important modifiable risk factors for coronary heart disease (CHD) in the United States .
KeywordsNicotinic Acid Statin Therapy Framingham Risk Score hsCRP Level Bile Acid Sequestrant
- 1.Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–96.CrossRefGoogle Scholar
- 10.Sever PS et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361(9364):1149–58.PubMedCrossRefGoogle Scholar
- 19.Harris WS et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009;119(6):902–7.PubMedCrossRefGoogle Scholar